Celcuity (CELC) Shares Outstanding (Weighted Average) (2016 - 2025)

Celcuity (CELC) reported Shares Outstanding (Weighted Average) of $46.8 million for Q4 2025, up 18.53% on a YoY basis from $39.4 million in Q4 2024, and down 1.75% quarter-over-quarter from $47.6 million in Q3 2025.

Celcuity (CELC) Shares Outstanding (Weighted Average) (2016 - 2025) Analysis & Trends

Celcuity has reported Shares Outstanding (Weighted Average) for 10 years, with the latest figure at $46.8 million in Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 18.53% year-over-year to $46.8 million; the trailing twelve-month figure through Dec 2025 stood at $46.8 million (up 18.53% YoY), and the FY2025 full-year result was $46.8 million, up 314.93% from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 stood at $46.8 million, down from $47.6 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $47.6 million in Q3 2025, with the low at $11.1 million in Q1 2021.
  • Historically, Shares Outstanding (Weighted Average) has averaged $26.7 million across 5 years, with a median of $22.0 million in 2023.
  • Annual changes were most pronounced in 2021 — Shares Outstanding (Weighted Average) advanced 7.98% — and 2024, when it jumped 93.48%.
  • Celcuity's Shares Outstanding (Weighted Average) stood at $13.4 million in 2021, then gained by 15.21% to $15.4 million in 2022, then soared by 53.58% to $23.7 million in 2023, then soared by 66.6% to $39.4 million in 2024, then rose by 18.53% to $46.8 million in 2025.
  • The last three Shares Outstanding (Weighted Average) figures came in at $46.8 million (Q4 2025), $47.6 million (Q3 2025), and $43.7 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 185,491.37 Bn
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 4,489.46 Bn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 100.00 Bn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 118.76 Bn
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - 417.01 Bn
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 254.10 Mn
9 Abivax 91.71 Bn 91.71 Bn - 928.40 Mn
10 Celcuity 4.14 Bn 3.42 Bn - 46.76 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 46.76 Mn
Sep 30, 2025 47.59 Mn
Jun 30, 2025 43.66 Mn
Mar 31, 2025 43.05 Mn
Dec 31, 2024 39.45 Mn
Sep 30, 2024 42.79 Mn
Jun 30, 2024 38.44 Mn
Mar 31, 2024 33.61 Mn
Dec 31, 2023 23.68 Mn
Sep 30, 2023 22.12 Mn
Jun 30, 2023 21.96 Mn
Mar 31, 2023 21.68 Mn
Dec 31, 2022 15.42 Mn
Sep 30, 2022 14.94 Mn
Jun 30, 2022 14.92 Mn
Mar 31, 2022 14.92 Mn
Dec 31, 2021 13.38 Mn
Sep 30, 2021 12.87 Mn
Jun 30, 2021 11.85 Mn
Mar 31, 2021 11.07 Mn